New Zealand

Livingbridge sells rehabilitation provider Habit Health to Five V Capital

London-based mid-market private equity investor Livingbridge has sold Habit Health, a leading provider of integrated rehabilitation and mental health services in New Zealand, to Australasia-based PE firm, Five V Capital.

August 9, 2024

Stonepeak to buy New Zealand retirement village operator Arvida Group for $1.25 billion

Alternative US investment firm Stonepeak is buying out New Zealand retirement village operator Arvida Group Limited in an all-cash deal valued at $1.25 billion.

July 26, 2024

Could New Zealand’s retirement village business model work elsewhere?

Paul Morgan, CEO of Wallacea Living, a luxury UK retirement village provider, recently went on a trip to New Zealand to see what could be learnt from its retirement village sector. He shared some of his findings with us.

May 9, 2024

75 years on: is the future of the NHS private?

The UK NHS was once globally revered, but cracks are showing as it marks seventy-five years and a question mark hangs over its future. HBI asks half a dozen experts what role for-profits have in its future - and whether it will it last another 75 years.

July 14, 2023

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion.

April 19, 2023

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.

April 6, 2023

UAE sovereign wealth fund “targets $2.5bn Diaverum”

Abu Dhabi sovereign wealth fund Mubadala Investment Co is considering the acquisition of $2.5bn Swedish pan-European dialysis group Diaverum, according to reports.

March 31, 2023

What does Kiwi deal tell us about Bupa’s plans?

Bupa appears to be selling off its New Zealand nursing home arm. What does this mean for the rest of its huge health care services portfolio – which generated revenue of £3.74bn in 2021 – and of its long-term strategy?

August 24, 2022

US homecare tech specialist buys Home Instead

US-based homecare tech specialist Honor Technology has acquired Home Instead, the global leader of franchise homecare services. The deal creates a global homecare group worth more than $2.1 billion in homecare revenue. HBI chats with sources including Home Instead's UK CEO to find out what the deal means for markets outside of the United States.

August 19, 2021

Bupa shift towards digital could impact M&A

Bupa’s new CEO Iñaki Ereño has announced a new strategy for the international health insurer and service group including making 40% of customer care touchpoints Bupa-owned, and having 60% active digital customers. What does this mean for Bupa's M&A strategy going forward? We talk to consultancy Candesic to find out more.

August 5, 2021

Older posts

New Zealand

August 9, 2024

July 26, 2024

May 9, 2024

July 14, 2023

April 19, 2023

April 6, 2023

March 31, 2023

August 24, 2022

August 19, 2021

August 5, 2021

Our Services

Company

Resources

Our Services

Company

Resources

Find Us

Please wait while your search results are being generated.

Get a CLEAR picture on private healthcare services across Europe

Subscribe now to Healthcare Europa and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture on private healthcare services across Emerging Markets

Subscribe now to Healthcare Nova and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture of ALL the top players in 22 sectors across 34 countries

Subscribe now to the only database of the Top 1,700 operators in Europe. Use it to:

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Get a CLEAR picture of the Top 1,300 players in Emerging Markets

Subscribe now to the only database of the Top 1,300 private healthcare operators in Emerging Markets . Use it to:

check

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Know the pulse of the market
from just £1040.

Know the pulse of the market
from just £1040.

Subscribe now to the only database of the
Top 1,700 operators in Europe. Use it to:

Instant access plus ongoing updates
from £1,895.

Subscribe now to the only database of the Top 1,300 private
healthcare operators in Emerging Markets . Use it to:

Instant access plus ongoing updates
from £1,895.